Research On The Development Strategy Of R Pharmaceutical Company Under The Background Of "two-invoice System"

With the rapid development of China’s economy and the deepening of medical reform,the medical insurance system of our residents has gradually improved,and the attention to their own health has also been continuously improved.China’s pharmaceutical industry is in a period of rapid development.With the continuous strengthening of policies,the market is gradually developing towards centralized and large-scale,which poses new challenges for the development and operation of pharmaceutical circulation enterprises.With the gradual implementation of the new medical reform policy,the "two-vote system" and other policies have come to the fore,and the development of small and medium-sized pharmaceutical circulation enterprises has been affected unprecedentedly.This article takes R Pharmaceutical Company as an example and uses relevant theoretical knowledge to study the "two-vote system".In the context of implementation,the company’s development orientation for itself and the corporate development strategy for the implementation of the "two-vote system".Firstly,this paper elaborates on the development status of the pharmaceutical circulation industry,reviews related concepts such as strategic management theory,elaborates the tools and methods used in strategic analysis,and then analyzes the development status and internal environment of R pharmaceutical companies.Summarize the main problems in the development process,and then use the PEST analysis tool to analyze the external environment of R pharmaceutical company in detail,elaborate the environment facing the development of the industry,and analyze the R pharmaceutical company from five aspects by using the five-force model.The company’s competitiveness and challenges,and then use SWOT analysis to summarize the advantages and disadvantages of its development,and to develop SWOT analysis matrix based on the above analysis,and select the R pharmaceutical company in the context of "two-vote system".The overall strategy and the development of corresponding implementation methods,put forward strategic safeguards.This paper believes that R Pharmaceutical Company should choose a diversified development strategy after the implementation of the "two-vote system",strengthen its own services,strive for cooperation with upstream suppliers,strengthen its own software and hardware construction,and improve the overall pharmaceutical distribution of enterprises.The ability to enhance the influence of local distribution,and gradually realize the transformation and development of the company through the development of third-party logistics,thus occupying a place in the pharmaceutical industry with constantly changing policies.